Article: Activity of pazopanib in
Oncoscience
2023 Volume 10, Page(s) 44–53
Abstract: Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma. In this case report, we discuss the case of a patient with ... ...
Abstract | Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma. In this case report, we discuss the case of a patient with a |
---|---|
Language | English |
Publishing date | 2023-09-20 |
Publishing country | United States |
Document type | Case Reports |
ISSN | 2331-4737 |
ISSN | 2331-4737 |
DOI | 10.18632/oncoscience.587 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.